In Madagascar, PSI works with the Malagasy people to promote malaria and HIV prevention, sexual and reproductive health and maternal, newborn and child health to ensure that everyone in Madagascar receives quality healthcare.
Our Presence in
PSI Madagascar was founded in 1998 to help priority populations and those with low incomes gain access to essential health products, services and information. Since then, its activities have expanded to include programs focused on child survival, malaria, reproductive health and HIV.
PSI Madagascar estimates that in 2018, its products and services provided 2,089,278 years of healthy life for the people of Madagascar, including:
years of life free from malaria
years of healthy life provided by its sexual and reproductive health programs
years of life free of HIV and other sexually transmitted infections
years of healthy life for new mothers and their babies
years of quality sanitation and clean water
We Focus On
PSI Madagascar provides quality sexual and reproductive health services to reach Malagasy national objectives, as well as the international Family Planning 2020 goals, and to expand contraceptive method choice across the country. PSI Madagascar works with the Malagasy government to integrate innovative sexual and reproductive health programs into private networks and public facilities to reach rural and remote areas with mobile clinic services.
To reduce maternal mortality and morbidity, PSI Madagascar expands access to quality post-abortion care services and harm reduction counseling in 18 regions of the country. PSI Madagascar also works with the Malagasy government to integrate innovative maternal health programs into private networks and public facilities. As part of this work, PSI Madagascar successfully registered Ace Miso as the first misoprostol for gynecological indications and distributes it nationwide.
As a principal recipient of the Global Fund, PSI Madagascar focuses on prevention activities to reduce the number of new HIV infections among key populations and the general population by the end of 2020. PSI Madagascar’s work expands facility and community-based HIV prevention, testing, treatment and care services for key populations in 22 regions.
To reach the goal of targeted geographic and progressive malaria in Madagascar, PSI Madagascar works with the Malagasy Ministry of Health and the National Malaria Control Program to provide access to high quality rapid diagnostic tests and antimalarial drugs, as well as insecticide-treated nets. PSI Madagascar also supports microscopy diagnosis improvement and surveillance for the elimination of malaria in two districts.
Discover what's happening at PSI
Ask Kelly: ETHICS DURING COVID-19- Returning to In-person Research
By: Kelly O’Keefe, Research Ethics Senior Technical Advisor, PSI; Jennifer Wheeler, Deputy Director for Research, PSI; and Kristen Little, Senior Technical Advisor, Strategic Research, PSI Since the
In Memoriam to Bill Gates, Sr.
By Karl Hofmann, President & CEO, PSI Let me add our voices to those who have paid tribute to Bill Gates, Sr. His remarkable contributions to the work of
Infected and Affected: The Indirect Consequences of COVID-19 in Central America
By Jennifer Wheeler, PSI Deputy Director, Research, Paola Letona, PSI Evidence Regional Director, LAC, and Sussy Lungo, Regional Executive Director, Asociación PASMO “When you are
Five Market Indicators that Signal the Hormonal IUS will take off
By Kendal Danna, PSI Technical Advisor, Reproductive Health In 2017, with USAID support, PSI began piloting the introduction of the hormonal Intrauterine System (IUS), also